Axera Pharma Private Limited
About Axera Pharma Private Limited
Data last updated:
Axera Pharma Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the management consultancy segment of the business services sector. It was incorporated on 27 April 2005.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2005PTC152841.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Smriti Rajesh Agrawal and Aayush Madhusudan Agrawal.
Its last annual general meeting (AGM) was held on 24 September 2015, and its latest financial statements are for the year ended 31 March 2015. The registered office was at Ajanta Housekandivli (W), Mumbai, Maharashtra, India – 400067.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressAjanta Housekandivli (W), Mumbai, Maharashtra, India – 400067
- IndustryBusiness Services, Management Consultancy
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Axera Pharma Private Limited FY 2015 filings available
Financial Statement Summary of Axera Pharma Private Limited
| Metrics | FY 2014-15 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | •••• |
| Other Income | •••• |
| Total Revenue | •••• |
| Cost of Materials Consumed | •••• |
| Employee Benefit Expense | •••• |
| Finance Costs | •••• |
| Depreciation and Amortisation | •••• |
| Other Expenses | •••• |
| Total Expenses | •••• |
| EBITDA | •••• |
| Profit Before Tax | •••• |
| Tax Expense | •••• |
| Net Profit (PAT) | •••• |
| Balance Sheet | |
| Share Capital | •••• |
| Reserves and Surplus | •••• |
| Net Worth (Total Equity) | •••• |
| Long-term Borrowings | •••• |
| Short-term Borrowings | •••• |
| Trade Payables | •••• |
| Total Liabilities | •••• |
| Fixed Assets | •••• |
| Investments | •••• |
| Inventories | •••• |
| Trade Receivables | •••• |
| Cash and Bank Balance | •••• |
| Total Assets | •••• |
Financial Ratios of Axera Pharma Private Limited
| Metrics | FY 2014-15 |
|---|---|
| Profitability | |
| EBITDA Margin | •••• |
| Net Profit Margin | •••• |
| Return on Equity (ROE) | •••• |
| Return on Capital Employed (ROCE) | •••• |
| Return on Assets (ROA) | •••• |
| Liquidity and Debt | |
| Current Ratio | •••• |
| Quick Ratio | •••• |
| Debt-to-Equity Ratio | •••• |
| Interest Coverage Ratio | •••• |
| Efficiency and Growth | |
| Asset Turnover | •••• |
| Receivable Days | •••• |
| Payable Days | •••• |
| Inventory Days | •••• |
| Revenue Growth | •••• |
| Net Profit Growth | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Axera Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Axera Pharma Private Limited
Axera Pharma has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Smriti Rajesh Agrawal Also directs: Anvaxx Laboratories LLP, Riteaid Enterprises LLP, Wyvern Ventures Private Limited and 3 more | Director | 18 Dec 2013 | 12 Years 9 Months | As last reported |
| Aayush Madhusudan Agrawal | Director | 14 Jan 2011 | 15 Years 8 Months | As last reported |
Charges & Borrowings of Axera Pharma Private Limited
Axera Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Axera Pharma Private Limited
Employment history and EPFO contributions of people linked to Axera Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Axera Pharma Private Limited
Axera Pharma Private Limited has 9 board changes on record since 2010: 2 appointments and 7 cessations. The latest: Smriti Rajesh Agrawal ceased to be Additional Director on 13 Aug 2014.
Credit Ratings, Litigation & Regulatory Alerts for Axera Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Axera Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Axera Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Axera Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Axera Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Axera Pharma Private Limited
Axera Pharma has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Axera Pharma was a private limited company based in Mumbai, Maharashtra, India. The company worked in management consultancy, within the business services industry. It was incorporated on 27 April 2005 and is registered under CIN U24230MH2005PTC152841. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Axera Pharma is U24230MH2005PTC152841. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Axera Pharma had 2 directors:
- Smriti Rajesh Agrawal - Director
- Aayush Madhusudan Agrawal - Director
Axera Pharma was incorporated on 27 April 2005. It is registered with the Registrar of Companies, Mumbai.
The registered office of Axera Pharma is at Ajanta Housekandivli W, Mumbai, Maharashtra, India – 400067.
Axera Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Axera Pharma operated in the business services industry, in the management consultancy segment.
No. Axera Pharma is not listed on any stock exchange. It is an unlisted company.
Smriti Rajesh Agrawal ceased to be Additional Director on 13 Aug 2014. Manisha Yogesh Agrawal ceased to be Director on 18 Dec 2013. Richa Ravi Agrawal ceased to be Director on 18 Dec 2013. Axera Pharma has 9 board changes on record in total.